Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: the GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumab - Stroes, E; Colquhoun, D; Sullivan, DGAUSS-2 Investigators (J Am Coll Cardiol, 2014)
et al.